Results 101 to 110 of about 44,282 (186)

Enalapril in patients after mitral valve replacement

Кардиоваскулярная терапия и профилактика, 2007
Aim. To assess enalapril effectiveness in myocardial remodeling correction among patients after mitral valve replacement. Material and methods. In total, 54 patients (mean age 46,3±7,6 years) with isolated or prevalent mitral valve stenosis were examined.
O. L. Barbarash, E. V. Tavlueva, Yu. V. Krotikov, I. N. Sizova, L. S. Barbarash   +4 more
doaj  

Felodipine-metoprolol combination tablet: A valuable option to initiate antihypertensive therapy? [PDF]

, 2017
The aim of the present study was to assess the efficacy and tolerability of a calcium antagonist/β-blocker fixed combination tablet used as first-line antihypertesnive therapy in comparison with an angiotensin converting enzyme inhibitor and placebo ...
Dahlöf, Björn, Detry, Jean-Marie, Gundersen, Torstein, Hosie, James, Januszewicz, Wlodzimierz, Lindström, Carl J., Magometschnigg, Dieter, Puig, Juan G., Safar, Michel, Tanser, Paul, Toutouzas, Pavlos, Waeber, Bernard   +11 more
core  

FUNCTIONAL STATE DYNAMICS OF BLOOD CELLS AND ENDOTHELIUM IN PATIENTS WITH ESSENTIAL HYPERTENSION WITH ENALAPRIL TREATMENT

Российский кардиологический журнал, 2003
The influence of ACE inhibitor enalapril therapy on functional activity of blood cells and vasomotor function of endothelium in patients with essential hypertension (EH) was studied.
O. M. Moisseyeva, O. A. Berkovich, S. V. Villevalde, E. A. Lyasnikova, I. V. Emelyanov   +4 more
doaj  

Underuse of indicated medications in elderly [PDF]

, 2015
Introduction: Treatment omissions are very important to value the quality of pharmacological therapy. In fact, suboptimal prescribing has been defined as overuse (polypharmacy), inappropriate prescribing (drug whose risks are greater than the benefits ...
Ariza-Zafra, Gabriel, Bellido-Estevez, Inmaculada, Blanco-Reina, Encarnacion, Medina-Cáliz, Inmaculada, Márquez, Elisa I., Ocaña-Riola, Ricardo   +5 more
core  

Administration of enalapril for preparation ofpatients with arterial hypertension to surgical interventions

Терапевтический архив, 2003
Aim. To study efficacy of enalapril, ACE inhibitor, in preparation to surgery of hypertensive patients with concomitant surgical diseases. Material and methods.
K I Proschaev
doaj  

The Effects of Different Treatments on Serum Trace Element Levels in Dogs with Heart Failure

Animals
The prognostic and diagnostic role of some trace elements in heart diseases has been demonstrated. In this study, the effects of min. 30-day and min.
Bengü Bilgiç, Duygu Tarhan, Mehmet Erman Or   +2 more
doaj   +1 more source

Protective Effects of Enalapril on Reducing Sensorimotor Dysfunctions of Ischemic Stroke is enhanced by Its Combination with Alpha Tocopherol

Journal of Ardabil University of Medical Sciences, 2017
Background & objectives: Ischemic stroke has complex pathophysiology and its treatment with single neuroprotective drugs has so far failed. Combination therapy could produce amplified protective effects via different mechanisms.
Hamdollah Panahpour, Adel Haghnejad Azar
doaj  

Enalapril therapy and thrombotic or inflammatory disturbances in essential arterial hypertension

Российский кардиологический журнал, 2005
The authors studied enalapril therapy perspectives for correction of factors related to arterial thrombosis and inflammatory disturbances development in vascular wall among patients with essential arterial hypertension (EAR).
O. M. Moiseeva, O. A. Berkovich, S. V. Villevalde, I. V. Emelyanov   +3 more
doaj  

Quality of medicines for Cardio-Vascular Diseases (CVDs) in the Ethiopian border with Kenya: The case of enalapril maleate and furosemide tablet quality in Borena and Gedeo zones.

PLOS Global Public Health
Hypertension (HTN), a cardiovascular disease (CV), is a major public health challenge. Therefore, the quality of drugs used to treat it has become a major concern. Enalapril and furosemide are among the drugs prescribed to manage hypertension.
Esayas Tesfaye, Fisseha Woldegiorgis, Tadele Eticha, Ayenew Ashenef   +3 more
doaj   +1 more source

Characterization of the circulating markers of the renin‐angiotensin‐aldosterone system in telmisartan‐ or enalapril‐treated dogs with proteinuric chronic kidney disease

Journal of Veterinary Internal Medicine
Background Effects of the renin‐angiotensin‐aldosterone system (RAAS) inhibitors enalapril and telmisartan on circulating RAAS in dogs with proteinuric chronic kidney disease (pCKD) are undescribed.
Joanna E. Murdoch, Bianca N. Lourenço, Roy D. Berghaus, Marisa K. Ames, Hillary K. Hammond, Amanda E. Coleman   +5 more
doaj   +1 more source